NASDAQ:ACAD

Acadia Pharmaceuticals Stock Forecast

etoro logo Buy ACAD
*Your capital is at risk
$21.27
+0.175 (+0.83%)
At Close: Jun 15, 2026
AI Analysis AI Analysis of ACAD AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ACAD to Watchlist?
Some Reasons Why To Add ACAD:
  • High gross margin of 91.5%
  • Strong return on equity of 35.6%
  • Low bankruptcy risk (Altman Z-Score: 6.00)
PDF

ACADIA Pharmaceuticals Inc. stock downgraded from Hold/Accumulate to Sell Candidate after Monday trading session
(Updated on Jun 15, 2026)

Sell candidate since Jun 15, 2026

The ACADIA Pharmaceuticals Inc. stock price gained 0.83% on the last trading day (Monday, 15th Jun 2026), rising from $21.09 to $21.27. During the last trading day the stock fluctuated 1.62% from a day low at $21.05 to a day high of $21.39. The price has risen in 6 of the last 10 days but is still down by -1.18% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 277 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $21.92 million.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect ACADIA Pharmaceuticals Inc. stock with a 90% probability to be traded between $20.38 and $22.54 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

ACAD Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The ACADIA Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $21.44 and $21.65. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 09, 2026, and so far it has fallen -2.63%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for ACADIA Pharmaceuticals Inc. stock

ACADIA Pharmaceuticals Inc. finds support from accumulated volume at $21.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.340 between high and low, or 1.62%. For the last week the stock has had daily average volatility of 2.88%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ACAD) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect ACADIA Pharmaceuticals Inc. to open at $21.24, and during the day (based on 14 day Average True Range), to move between $20.95 and $21.58, which gives a possible trading interval of +/-$0.636 (+/-3.04%) up or down from last closing price. If ACADIA Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 3.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $21.25 (0.07%) than the resistance at $21.39 (0.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ACADIA Pharmaceuticals Inc. stock A Buy?

ACADIA Pharmaceuticals Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.224 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 16, 2026 - $21.24 ( 0.141%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ACAD Performance

Trading levels for ACAD

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 21.58 1.46%
R2 21.45 0.85%
R1 21.36 0.470%
Price 21.27
S1 21.11 -0.752%
S2 21.02 -1.13%
S3 20.90 -1.74%

Accumulated Volume Support & Resistance Levels

Level Price
R3 22.17 4.26%
R2 22.09 3.88%
R1 21.39 0.588%
Price 21.27
S1 21.25 -0.0705%
S2 20.74 -2.47%
S3 20.32 -4.44%

FAQ

What is the symbol for ACADIA Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for ACADIA Pharmaceuticals Inc. is ACAD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ACADIA Pharmaceuticals Inc. Stock?
ACADIA Pharmaceuticals Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy ACADIA Pharmaceuticals Inc. Stock?
ACADIA Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ACADIA Pharmaceuticals Inc. Stock.

What's the current price of ACADIA Pharmaceuticals Inc. Stock?
As of the end of day on the Jun 15, 2026, the price of an ACADIA Pharmaceuticals Inc. (ACAD) share was $21.27.

What is the 52-week high and low for ACADIA Pharmaceuticals Inc. Stock?
The 52-week high for ACADIA Pharmaceuticals Inc. Stock is $28.35 and the 52-week low is $19.69.

What is the market capitalization of ACADIA Pharmaceuticals Inc. Stock?
As of the Jun 15, 2026, the market capitalization of ACADIA Pharmaceuticals Inc. is 3.641B.

When is the next earnings date for ACADIA Pharmaceuticals Inc.?
The upcoming earnings date for ACADIA Pharmaceuticals Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT ACADIA PHARMACEUTICALS INC.
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.84
4.82% Jun 11
EAT
$140.46
11.23% Jun 05
TPR
$140.47
7.49% Jun 04
LITE
$905.00
5.77% Jun 01
W
WCLD
$27.34
12.84% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE